Adverse Event Prediction in Geriatric Patients in the ED With Ultrasound

NCT05369962 | Completed

• 1 other identifier: 202100945
• Study Type: observational
• Target: 68
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to evaluate whether ultrasound measurements of the Qcsa can be utilized to identify older patients who are at risk for functional decline, ED revisit or death.

Conditions

Frailty; Adverse Event

Outcome Measures

Primary Outcomes (3)

• Ultrasound Qcsa

  POCUS Qcsa in older patients in the ED.

  1 day of admission to ED

• ED revisit

  Is there a relation between the performed POCUS Qcsa measurement at ED visit and ED revisit in older patients.

  3 months

• Mortality

  Is there a relation between the performed POCUS Qcsa measurement at ED visit and mortality in older patients.

  3 months

Secondary Outcomes (4)

• ED revisit: Ultrasound Qcsa versus Karnofsky Performance Score

  3 months

• Mortality: Ultrasound Qcsa versus Karnofsky Performance Score

  3 months

• ED revisit: Ultrasound Qcsa plus Karnofsky Performance Score

  3 months

• Mortality: Ultrasound Qcsa plus Karnofsky Performance Score

  3 months

Interventions

Ultrasound DEVICE

Ultrasound measurements of the Qcsa

Eligibility Criteria

• Age: 70 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients \>70 years and older presenting in the ED of the UMCG hospital who are participating in the Acutelines bio-databank are eligible for inclusion.

You may qualify if:

• Age (\>70 years)
• Presenting to the ED of the UMCG for one of the following specialties: internal medicine, nephrology, geriatric medicine, oncology, hematology, lung medicine, gastrointestinal/liver medicine, or emergency medicine (non-trauma).
• Consent obtained for participation in the Acutelines bio-databank

You may not qualify if:

• Unable to obtain ultrasound image of rectus femoris (e.g. amputation, edema)
• Paresis or paralysis of one or both legs

Sponsors & Collaborators

• University Medical Center Groningen: lead

Study Sites (1)

UMCG

Groningen, Netherlands

Location

MeSH Terms

Conditions

Frailty

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

Pathologic Processes; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic Imaging; Diagnostic Techniques and Procedures; Diagnosis

Study Officials

• Svenja Haak

  University Medical Center Groningen

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 3 Months
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: March 21, 2022
• First Posted: May 11, 2022
• Study Start: May 10, 2022
• Primary Completion: February 18, 2023
• Study Completion: May 20, 2023
• Last Updated: March 27, 2025

Record last verified: 2025-03

Data Sharing

• IPD Sharing: Will not share

Locations

NL (1)